A Single Bolus, 12-hour Euglycemic Clamp Study of the Safety, Pharmacokinetics (PK) and Glucodynamics (GD) of Intraperitoneal (IP) Portal Insulin U-500

Clinical trial NCT07341373 · RECRUITING

Trial details

NCT number: NCT07341373
Sponsor: Portal Diabetes, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2026-02-10
Primary completion: 2026-09-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.